Navigation Links
Aureus Pharma Releases New Unified Knowledge Database
Date:8/18/2008

AurSCOPE(R) Global Pharmacology Space and Drug Target Knowledge Databases

Related to Nuclear Receptors and Proteases

PARIS, August 18 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions that accelerate life sciences discovery, announced today the release of three new AurSCOPE(R) Target knowledge databases. The new offerings include knowledge databases for the important drug targets Nuclear Receptor and Protease, as well as the centralized product AurSCOPE(R) Global Pharmacology Space (AurSCOPE(R) GPS). AurSCOPE GPS comprises all of the pharmaceutically important therapeutic targets including G-Protein coupled receptors (GPCR), kinases, ion channels, nuclear receptors and proteases.

Nuclear receptor proteins are integral to critical metabolic processes and implicated in diseases including diabetes, cancer, and heart disease. Likewise, proteases are a major focus for therapeutic intervention being linked to viral diseases including HIV, inflammation and neurogenerative disorders.

AurSCOPE GPS and other AurSCOPE Knowledge databases streamline discovery efforts with thorough assessment of selectivity and off-target effects at the earliest stages of the drug discovery pipeline.

"The release of AurSCOPE Global Pharmacology Space (GPS), Nuclear Receptor and Protease represents an exciting milestone for Aureus Pharma. These powerful new products considerably extend Aureus' knowledge management solution by providing our pharmaceutical customers unique access to the druggable therapeutic target space." said Jason Theodosiou, President and CEO of Aureus Pharma. "Using AurSCOPE Knowledge databases, researchers easily employ knowledge-driven hypotheses to drive better informed decisions during drug discovery."

Aureus experts will demonstrate AurSCOPE GPS, AurSCOPE Nuclear Receptor and AurSCOPE Protease products at the American Chemical Society (ACS) meeting in Philadelphia, PA August 18th -
'/>"/>

SOURCE Aureus Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
2. Aureus Pharma Announces Date of 2008 Annual User Symposium
3. QSB Anti-Virulence Platform Inhibits Biofilm Formation by Staphylococcus Aureus MRSA and Candida sp
4. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
5. New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA)
6. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
7. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
8. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
9. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
10. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
11. Ondine Biopharma Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 BerGenBio ... today announces that an abstract on the latest data ... of the Axl receptor tyrosine kinase, and BGB10C9, an ... has been published in conjunction with the 2015 American ... Chicago , May 29 - June 2, ...
(Date:5/29/2015)... , May 29, 2015 ... as p ersonalized   treatments enter arena, ... Despite generic erosion facing several of the ... Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global market ... by the end of the decade.   ...
(Date:5/29/2015)... 2015 When a leading manufacturer ... request to design an industrial oven ... medications being produced using a 3D-printing process, Gruenberg ... robotic gantry, heat-saving windows, and internal actuators and ... 3D-printed pills to exact specifications. , To ensure ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... their offering. This report deals with ... classical use mainly to describe the chromosome structure ... age of molecular biology, it is also referred ...
Breaking Biology Technology:BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 2Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 3New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3
... Technology Can Solve Pressing Food, Fuel Problems of ... ON, Dec. 3 /PRNewswire/ - Dr. David Dennis, FRSC, CEO of ... at a side event at the United Nations Climate Change Conference ... solved global problems in the 20th Century and the role it ...
... DEERFIELD, Ill., Dec. 3 Today, the International Society,for ... stem cell researchers, released new guidelines for the responsible,development ... A,Commentary article that summarizes the Guidelines for the ... Press in the December issue of Cell,Stem Cell, the ...
... VIENNA, Va., Dec. 3 In response to numerous,shareholder ... it has added updated pictures of it new manufacturing ... CEL-SCI,s homepage,( http://www.cel-sci.com ) by clicking on the link ... , CEL-SCI is ...
Cached Biology Technology:Leading Canadian Scientist to speak at UN Climate Change Conference 2The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 2The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 3The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy 4
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... - Coding variants in immune disease-related genes play only ... psoriasis, according to a new study led by Anhui ... by their investigation on the contribution of functional coding ... a large-scale investigation, researchers only discovered two independent low-frequency ...
... Baltimore, MD November 9, 2013 New research ... Americans with chronic kidney disease contribute to a more ... The research, led by investigators from the University of ... help explain, in part, why even after accounting for ...
... other devices that can change shape or move with ... may be possible through research led by the University ... when triggered by light, thereby converting light energy into ... machine components such as switches and power sources. ...
Cached Biology News:The contribution of coding variants to psoriasis much smaller than thought 2Genetic variation increases risk of kidney disease progression in African-Americans 2Genetic variation increases risk of kidney disease progression in African-Americans 3Genetic variation increases risk of kidney disease progression in African-Americans 4Snap to attention: Polymers that react and move to light 2
Sheep polyclonal to Quinolone ( Abpromise for all tested applications). Antigen: Norfloxacin(N)conjugated to BSA...
DONOR BOVINE SERUM AND PLASMA...
The Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 6 microcentrifuge tubes....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: